Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapy

BACKGROUND: Accurate risk stratification can help guide appropriate treatment decisions in men with localized prostate cancer. Here, we evaluated the independent ability of the molecular cell cycle progression (CCP) score and the combined cell-cycle clinical risk (CCR) score to predict 10-year risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Canter, Daniel J., Freedland, Stephen, Rajamani, Saradha, Latsis, Maria, Variano, Margaret, Halat, Shams, Tward, Jonathan, Cohen, Todd, Stone, Steven, Schlomm, Thorsten, Bishoff, Jay, Bardot, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027968/
https://www.ncbi.nlm.nih.gov/pubmed/31243337
http://dx.doi.org/10.1038/s41391-019-0159-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027968/
https://www.ncbi.nlm.nih.gov/pubmed/31243337
http://dx.doi.org/10.1038/s41391-019-0159-9

Ejemplares similares